DNER in Renal Cell Carcinoma: Gene Expression and Signaling Analysis

Anrui Li published a research document on figshare in May 2026, describing the role of the DNER gene in clear cell renal cell carcinoma (ccRCC). The study integrates bioinformatic analysis with experimental validation to explore DNER's function in metabolic reprogramming and immune microenvironment remodeling. The dataset is a 538.6 KB DOCX file containing the research findings.

Use Cases

• Studying the link between gene expression and metabolic pathway activity in ccRCC based on the described bioinformatic screening.
• Investigating the role of DNER in macrophage polarization and immunosuppressive microenvironment formation as described in the results.
• Analyzing the interaction between DNER and the JAK2/STAT3 signaling pathway for mechanistic cancer research.
• Exploring potential associations between gene overexpression and drug sensitivity, such as to PARP inhibitors, as suggested in the preliminary evidence.

Strengths

• The description provides a detailed mechanistic pathway linking DNER to glycolytic flux and immune modulation.
• Research integrates multiple validation methods including bioinformatics, in vitro, and in vivo assays as described.
• Dataset is openly licensed under CC-BY-4.0, permitting reuse and redistribution.

Limitations

• The primary data (e.g., gene expression matrices, experimental raw data) are not directly accessible; the file is a research document.
• Column-level documentation and sample data are unavailable, making direct computational analysis impossible without extracting information from the text.
• Row count and dataset structure are unknown, limiting suitability assessment for typical ML tasks.

Provenance

Source

Author Anrui Li, published on figshare.

Collection Method

Bioinformatic analyses integrated with experimental validation (in vitro, in vivo, mechanistic studies) as described.

Freshness

Last updated 2026-05-22 06:09:50.